HomeCompareEUCRU vs RYLD

EUCRU vs RYLD: Dividend Comparison 2026

EUCRU yields 19.96% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EUCRU wins by $28.3K in total portfolio value
10 years
EUCRU
EUCRU
● Live price
19.96%
Share price
$10.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.8K
Annual income
$6,710.30
Full EUCRU calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — EUCRU vs RYLD

📍 EUCRU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEUCRURYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EUCRU + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EUCRU pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EUCRU
Annual income on $10K today (after 15% tax)
$1,696.61/yr
After 10yr DRIP, annual income (after tax)
$5,703.76/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, EUCRU beats the other by $3,504.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EUCRU + RYLD for your $10,000?

EUCRU: 50%RYLD: 50%
100% RYLD50/50100% EUCRU
Portfolio after 10yr
$58.7K
Annual income
$4,648.82/yr
Blended yield
7.92%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EUCRU buys
0
RYLD buys
0
No recent congressional trades found for EUCRU or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEUCRURYLD
Forward yield19.96%12.14%
Annual dividend / share$2.00$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$72.8K$44.5K
Annual income after 10y$6,710.30$2,587.35
Total dividends collected$41.4K$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: EUCRU vs RYLD ($10,000, DRIP)

YearEUCRU PortfolioEUCRU Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$12,696$1,996.01$11,914$1,213.65+$782.00EUCRU
2$15,953$2,368.35$14,099$1,351.30+$1.9KEUCRU
3$19,851$2,781.24$16,580$1,494.55+$3.3KEUCRU
4$24,475$3,234.40$19,384$1,642.61+$5.1KEUCRU
5$29,915$3,726.92$22,535$1,794.70+$7.4KEUCRU
6$36,267$4,257.31$26,063$1,950.00+$10.2KEUCRU
7$43,629$4,823.54$29,995$2,107.69+$13.6KEUCRU
8$52,106$5,423.11$34,361$2,266.99+$17.7KEUCRU
9$61,806$6,053.11$39,194$2,427.12+$22.6KEUCRU
10$72,843$6,710.30$44,525$2,587.35+$28.3KEUCRU

EUCRU vs RYLD: Complete Analysis 2026

EUCRUStock

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Full EUCRU Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this EUCRU vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EUCRU vs SCHDEUCRU vs JEPIEUCRU vs OEUCRU vs KOEUCRU vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.